EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Subscribe To Our Newsletter & Stay Updated
